L’anticorps anti-VLDLR Polyclonal Lapin est utilisé pour la détection de VLDLR dans des échantillons de Humain, Rat et Souris. Il a été validé pour WB et ELISA.
VLDLR
Reactivité: Humain, Souris
WB, FACS
Hôte: Lapin
Polyclonal
Cy5
Indications d'application
Optimal working dilutions should be determined experimentally by the investigator. Suggested starting dilutions are as follows: WB 1:500-2000,ELISA 1:5000-20000
Restrictions
For Research Use only
Format
Liquid
Concentration
1 mg/mL
Buffer
PBS, 50 % glycerol, 0.05 % Proclin 300, 0.05 %BSA
Agent conservateur
ProClin
Précaution d'utilisation
This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
Stock
-20 °C
Stockage commentaire
Stable for one year at -20°C from date of shipment. For maximum recovery of product, centrifuge the original vial after thawing and prior to removing the cap. Aliquot to avoid repeated freezing and thawing.
Date de péremption
12 months
Antigène
VLDLR
(Very Low Density Lipoprotein Receptor (VLDLR))
Autre désignation
VLDLR
Sujet
Very low-density lipoprotein receptor, VLDL receptor, VLDL-RVLDLR (Very Low Density Lipoprotein Receptor) is a Protein Coding gene. Diseases associated with VLDLR include Cerebellar Hypoplasia And Mental Retardation With Or Without Quadrupedal Locomotion 1 and Cerebellar Hypoplasia. Among its related pathways are Metabolism and Lipoprotein metabolism. The low density lipoprotein receptor (LDLR) gene family consists of cell surface proteins involved in receptor-mediated endocytosis of specific ligands. VLDLR encodes a lipoprotein receptor that is a member of the LDLR family and plays important roles in VLDL-triglyceride metabolism and the reelin signaling pathway. Alternative splicing generates multiple transcript variants encoding distinct isoforms for VLDLR.